Medicare Enrolled

Dr. Carlos Neghme, M.D.

Gastroenterology · San Marcos, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1305 WONDER WORLD DR, San Marcos, TX 78666
5127548676
In practice since 2005 (20 years)
NPI: 1215921937 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Neghme from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Neghme? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Neghme

Dr. Carlos Neghme is a gastroenterology in San Marcos, TX, with 20 years in practice. Based on federal Medicare data, Dr. Neghme performed 649 Medicare services across 631 unique beneficiaries.

Between the years covered by Open Payments, Dr. Neghme received a total of $13,246 from 56 pharmaceutical and/or device companies across 816 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Neghme is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 47% volume in TX$ $13,246 industry payments

Medicare Practice Summary

Medicare Utilization ↗
649
Medicare services
Top 47% in TX for gastroenterology
631
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Removal of polyps or growths of large bowel using an endoscope with mechanical snare119$201$1,067
Colonoscopy with biopsy116$85$847
Upper GI endoscopy with biopsy102$56$680
Office visit, established patient (30-39 min)88$85$217
Office visit, established patient (20-29 min)81$59$148
New patient office visit (45-59 min)51$113$333
Insertion of guide wire with dilation of esophagus using a flexible endoscope32$100$701
New patient office visit (30-44 min)18$71$219
Colorectal cancer screening; colonoscopy on individual at high risk17$174$778
New patient office or other outpatient visit, 15-29 minutes14$47$151
Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare11$138$827
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,246
Total received (2018-2024)
Avg $1,892/year across 7 years
Top 16% in TX for gastroenterology
56
Companies
816
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,229 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,684
2023
$2,350
2022
$2,011
2021
$1,342
2020
$1,017
2019
$1,692
2018
$2,149

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,923
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,794
AbbVie Inc.
$963
AbbVie, Inc.
$880
Celgene Corporation
$782
QOL Medical, LLC
$738
Janssen Biotech, Inc.
$570
Takeda Pharmaceuticals U.S.A., Inc.
$530
Gilead Sciences, Inc.
$478
PFIZER INC.
$400
Ferring Pharmaceuticals Inc.
$267
Lilly USA, LLC
$267
UCB, Inc.
$241
Phathom Pharmaceuticals, Inc.
$221
Daiichi Sankyo Inc.
$207
Regeneron Healthcare Solutions, Inc.
$191
Intercept Pharmaceuticals, Inc.
$177
INTERCEPT PHARMACEUTICALS, INC.
$177
Evoke Pharma, Inc.
$174
Allergan Inc.
$151
Merck Sharp & Dohme LLC
$139
Ardelyx, Inc.
$135
FUJIFILM Healthcare Americas Corporation
$125
Janssen Scientific Affairs, LLC
$122
Romark Laboratories, LC
$122
Braintree Laboratories, Inc.
$116
Ironwood Pharmaceuticals, Inc
$102
Celltrion USA Inc.
$100
Nestle HealthCare Nutrition Inc.
$90
Pharmacosmos Therapeutics Inc.
$88
Johnson & Johnson Health Care Systems Inc.
$84
RedHill Biopharma Inc.
$80
GENZYME CORPORATION
$77
AIMMUNE THERAPEUTICS, INC.
$74
Ipsen Biopharmaceuticals, Inc
$71
Merck Sharp & Dohme Corporation
$61
Shire North American Group Inc
$51
AMAG Pharmaceuticals, Inc.
$45
NESTLE HEALTHCARE NUTRITION INC.
$43
Amgen Inc.
$40
IRONWOOD PHARMACEUTICALS, INC
$39
Synergy Pharmaceuticals Inc
$39
Prometheus Laboratories Inc.
$38
Organon LLC
$36
Ethicon US, LLC
$27
Madrigal Pharmaceuticals
$25
Olympus America Inc.
$22
Micro-tech Endoscopy USA, Inc.
$18
Medtronic, Inc.
$17
Alnylam Pharmaceuticals Inc.
$15
Sandoz Inc.
$15
PORTOLA PHARMACEUTICALS, INC.
$15
Shield Therapeutics Inc
$14
Cumberland Pharmaceuticals, Inc.
$13
GlaxoSmithKline, LLC.
$13
Napo Pharmaceuticals Inc
$4
Top 3 companies account for 35.3% of total payments
Associated products mentioned in payments ›
ACCRUFER · ALINIA · ANDEXXA · APRISO · AVSOLA · Aemcolo · Alinia · Alinia Tablets 500mg 30 count bottle · All Products · Amitiza · BYSTOLIC · Bylvay · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EVIS EXERA · Entyvio · FERAHEME · FUJIFILM · GATTEX · GIMOTI · GIVLAARI · HUMIRA · HYRIMOZ · Humira · IBSRELA · INFLECTRA · INJECTAFER · IQIRVO · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTEGRITY · Mavyret · Monoferric · Motegrity · Movantik · Mytesi · OCALIVA · OMVOH · Omeclamox · PILLCAM · REBYOTA · RELISTOR · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SHINGRIX · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS FOAM · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · YUFLYMA · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,041 per 100 Medicare services performed
Looking for a gastroenterology in San Marcos?
Compare gastroenterologys in the San Marcos area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
10
Per 100K population
3.9
County median income
$85,827
Nearest hospital
CHRISTUS SANTA ROSA HOSPITAL-SAN MARCOS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Neghme is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 16%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Neghme experienced with removal of polyps or growths of large bowel using an endoscope with mechanical snare?
Based on Medicare claims data, Dr. Neghme performed 119 removal of polyps or growths of large bowel using an endoscope with mechanical snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Neghme receive payments from pharmaceutical companies?
Yes. Dr. Neghme received a total of $13,246 from 56 companies across 816 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Neghme's costs compare to other gastroenterologys in San Marcos?
Dr. Neghme's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Neghme) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →